Literature DB >> 17955761

Prevalence and risk factors of gallstone disease in a high altitude Saudi population.

S A Abu-Eshy1, A A Mahfouz, A Badr, M N El Gamal, M Y Al-Shehri, M I Salati, M E Rabie.   

Abstract

To study the prevalence of gallstone disease and related risk factors in a Saudi Arabian population a cross-sectional community-based study was made of 291 people from Abha district, Asir region. A structured interview collected background data and all participants had upper abdominal ultrasonography to detect gallstones. The overall prevalence of gallstone disease was 11.7%. Using logistic regression multivariate analysis, the following were significant risk factors for gallstone disease: female sex, family history of gallstone disease and past history of pancreatitis. Age, education, blood pressure, smoking, coffee intake, overweight, diabetes mellitus, number of pregnancies and use of oral contraceptives were not significant risk factors. Discriminant analysis of symptoms showed that only right hypochondrium pain was significantly associated with gallstone disease.

Entities:  

Mesh:

Year:  2007        PMID: 17955761

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  10 in total

1.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

2.  Non-invasive assessment of choledocholithiasis in patients with gallstones and abnormal liver function.

Authors:  Bilal O Al-Jiffry; Abdeen Elfateh; Tariq Chundrigar; Bassem Othman; Owaid Almalki; Fares Rayza; Hashem Niyaz; Hesham Elmakhzangy; Mohammed Hatem
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Chemical composition of gallstones from Al-jouf province of saudi arabia.

Authors:  Bashir M Jarrar; Meshref A Al-Rowaili
Journal:  Malays J Med Sci       Date:  2011-04

4.  Smoking habits and gallbladder disease: a systematic review and meta-analysis study.

Authors:  V Papadopoulos; D Filippou; K Mimidis
Journal:  Hippokratia       Date:  2020 Oct-Dec       Impact factor: 0.471

5.  The Diagnostic Yield of Abdominal Ultrasounds Requested by Family Physicians at an Academic Hospital in Riyadh, Saudi Arabia.

Authors:  Haytham I AlSaif; Abdullah S Alzaid; Mohammed A Albabtain; Abdulmalik A Alharbi; Fahad K Alnahabi; Ahmad I Alarifi; Mohammed S Alqasoumi; Abdulrahman Y Alhawas; Saad M Alsaad
Journal:  Cureus       Date:  2022-06-01

6.  Epidemiological survey to determine the prevalence of cholecystolithiasis in Uyghur, Kazakh, and Han Ethnic Groups in the Xinjiang Uyghur Autonomous Region of China: cross-sectional studies.

Authors:  Fujun Lv; Guangjun Wang; Dandan Ding; Jiangwei Liu; Caifu Shen; Feng Ji; Yan Kang
Journal:  BMC Gastroenterol       Date:  2021-03-18       Impact factor: 3.067

7.  Compliance to endoscopic retrograde cholangiopancreatography according to current guidelines and adverse outcomes of suspected choledocholithiasis in an acute care setting.

Authors:  Abdulrahman Almaslamani; Rakan Aldusari; Hassan Arishi; Ahmed Alaamri; Faisal Almudaiheem; Sami Almutairi; Abdulhakim Alshuraymi; Sami El-Boghdadly
Journal:  Surg Endosc       Date:  2022-03-11       Impact factor: 3.453

8.  The prevalence and risk factors for gallstone disease in taiwanese vegetarians.

Authors:  Yen-Chun Chen; Chia Chiou; Ming-Nan Lin; Chin-Lon Lin
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

9.  A scoring system for the prediction of choledocholithiasis: a prospective cohort study.

Authors:  Bilal O Al-Jiffry; Samah Khayat; Elfatih Abdeen; Tasadooq Hussain; Mohammed Yassin
Journal:  Ann Saudi Med       Date:  2016 Jan-Feb       Impact factor: 1.526

10.  The Prevalence and Risk Factors of Gallstone Among Adults in South-East of Iran: A Population-Based Study.

Authors:  Alireza Ansari-Moghaddam; Alireza Khorram; Mahmodreza Miri-Bonjar; Mahdi Mohammadi; Hossein Ansari
Journal:  Glob J Health Sci       Date:  2015-07-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.